These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Efficacy of two once-daily methylphenidate formulations compared across dose levels at different times of the day: preliminary indications from a secondary analysis of the COMACS study data. Sonuga-Barke EJ, Swanson JM, Coghill D, DeCory HH, Hatch SJ. BMC Psychiatry; 2004 Sep 30; 4():28. PubMed ID: 15458569 [Abstract] [Full Text] [Related]
7. Methylphenidate controlled-delivery capsules (EquasymXL, Metadate CD): a review of its use in the treatment of children and adolescents with attention-deficit hyperactivity disorder. Anderson VR, Keating GM. Paediatr Drugs; 2006 Sep 30; 8(5):319-33. PubMed ID: 17037949 [Abstract] [Full Text] [Related]
10. Continuity of methylphenidate treatment for attention-deficit/hyperactivity disorder. Marcus SC, Wan GJ, Kemner JE, Olfson M. Arch Pediatr Adolesc Med; 2005 Jun 30; 159(6):572-8. PubMed ID: 15939858 [Abstract] [Full Text] [Related]